文献速递产科母胎医学

阿司匹林用于子痫前期预防的剂量:支持162毫克剂量的论据

Aspirin dose for preeclampsia prophylaxis: an argument for 162-mg dosing.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-11-29

本文论述子痫前期预防中阿司匹林的最佳剂量,指出国际指南缺乏共识;剂量≥100 mg疗效显著优于更低剂量,162 mg剂量对COX-1抑制作用保持高度特异性,且可克服部分患者对低剂量(如81 mg)的阿司匹林抵抗;采用150 mg剂量的当代随机对照试验显示不良事件较安慰剂未增加,证据日益支持162 mg为最佳剂量。

要点

  • 阿司匹林预防子痫前期存在剂量-反应关系,剂量≥100 mg疗效显著优于更低剂量。
  • 162 mg剂量对COX-1的抑制作用保持高度特异性,减少对前列腺素广泛抑制的担忧。
  • 部分患者因素(如妊娠期药代动力学改变或肥胖)可能降低低剂量(如81 mg)疗效,162 mg可克服阿司匹林抵抗。

核心结论

  • 当前证据日益支持162 mg为子痫前期预防的最佳剂量,疗效优于常用的81 mg剂量,且无明显证据表明风险增加。

研究设计与样本

  • 本文为论述性文章,围绕阿司匹林预防子痫前期的剂量问题汇总现有证据与指南现状。

主要发现

  • 阿司匹林通过选择性抑制环氧合酶-1(COX-1)、减少血栓素A2合成并保留前列环素生成而发挥获益。
  • 已确立剂量-反应关系,剂量≥100 mg疗效显著优于更低剂量。
  • 162 mg剂量下阿司匹林的药理作用对COX-1保持高度特异性。
  • 新兴证据提示妊娠期药代动力学改变或肥胖等患者因素可能降低低剂量(如81 mg)阿司匹林的疗效。
  • 在这些研究中,162 mg剂量成功克服了阿司匹林抵抗。

关键数值与推荐

  • 阿司匹林剂量≥100 mg疗效显著优于更低剂量。
  • 162 mg剂量对COX-1抑制作用保持高度特异性。
  • 低剂量(如81 mg)在部分患者中疗效可能降低,162 mg可克服阿司匹林抵抗。
  • 150 mg剂量随机对照试验中不良事件较安慰剂未增加。

临床怎么用

  • 原文结论为当前证据日益支持162 mg作为子痫前期预防的最佳剂量,疗效优于常用的81 mg剂量且无明显风险增加证据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The optimal aspirin dose for preeclampsia prevention remains controversial, with international guidelines lacking consensus on the most effective regimen. Aspirin is a proven intervention for reducing the risk of preeclampsia, particularly when initiated early in pregnancy. Its benefits stem from the selective inhibition of cyclooxygenase-1 (COX-1), reducing thromboxane A2 synthesis while preserving prostacyclin production, thereby restoring the vascular balance essential for placental health. A dose-response relationship has been established, with doses ≥100 mg showing significantly greater efficacy than lower doses. Furthermore, aspirin's pharmacological effects remain highly specific to COX-1 at the 162 mg dose, minimizing concerns about broader prostaglandin inhibition. Emerging evidence suggests that certain patient factors, such as altered pharmacokinetics during pregnancy or obesity, may reduce aspirin's effectiveness at lower doses (e.g., 81 mg). In these studies, aspirin resistance was successfully overcome with a 162 mg dose. While concerns regarding safety at this dose have been raised, contemporary randomized controlled trials utilizing a 150 mg dose have shown no increase in adverse effects compared to placebo. As such, current evidence increasingly supports 162 mg as the optimal dose for preeclampsia prevention, offering greater effectiveness than the commonly used 81 mg dose, without significant evidence of increased risk.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Jones Pullins ME, Boggess KA. Aspirin dose for preeclampsia prophylaxis: an argument for 162-mg dosing. Am J Obstet Gynecol MFM. 2024. PMID: 39615594. doi:10.1016/j.ajogmf.2024.101564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。